Coronavirus

Nairobi-based EquiLife Group is seeking $20m for a permanent capital vehicle aimed to help businesses affected by the crisis.

In these uncharted times, firms are rewriting term sheets and valuations are dropping. How will that impact current era funds?

Demand for sextech, gambling and cannabis products began to skyrocket when lockdowns began.

Analysts predict a global seed slowdown of 22% by the end of Q1 because of the covid-19 outbreak, US seed investors say not so fast.

Jury is still out, but heavily invested legacy vintages might suffer more than funds in the coming market.

SoftBank is close to finalizing a deal to lead a $300 million investment in Didi Chuxing's self-driving unit, reported The Information.

SOSV's labs, which have remained open during the national lockdown, have already worked with more than a dozen start-ups on the front lines of the covid-19 response.

Areas of the healthcare industry will likely be triggered into action, spurring innovation, as bottlenecks in the system become increasingly clear amid covid-19, says the venture and growth-equity investor.

Ready Responders, an on-demand healthcare service, has secured $48 million in Series B funding.

VCs are focused on their current portfolio and open to hear pitches. Just don't expect a ton of new deals.